Mark A. Nakasone
- Co-authors
- David FushmanMichael H. GlickmanBrian O. SmithDanny T. HuangNurit Livnat‐LevanonGary SibbetMads GabrielsenCarlos A. Castañeda
- Topics
- Ubiquitin and proteasome pathways (17 papers)Cancer-related Molecular Pathways (6 papers)Protein Degradation and Inhibitors (6 papers)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Mark A. Nakasone
18 papers receiving 570 citations
Peers
Comparison fields: 5 of 55
- Molecular Biology 516
- Oncology 223
- Epidemiology 110
- Cell Biology 68
- Genetics 54
Countries citing papers authored by Mark A. Nakasone
This map shows the geographic impact of Mark A. Nakasone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Nakasone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Nakasone more than expected).
Fields of papers citing papers by Mark A. Nakasone
This network shows the impact of papers produced by Mark A. Nakasone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Nakasone. The network helps show where Mark A. Nakasone may publish in the future.
Co-authorship network of co-authors of Mark A. Nakasone
This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Nakasone. A scholar is included among the top collaborators of Mark A. Nakasone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Nakasone. Mark A. Nakasone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 25 | |
| 3 | 30 | |
| 4 | 5 | |
| 5 | 67 | |
| 6 | 54 | |
| 7 | 34 | |
| 8 | 11 | |
| 9 | 6 | |
| 10 | 51 | |
| 11 | 20 | |
| 12 | 32 | |
| 13 | 40 | |
| 14 | 28 | |
| 15 | 85 | |
| 16 | 10 | |
| 17 | 52 | |
| 18 | 14 |
About Mark A. Nakasone
Mark A. Nakasone is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 18 papers that have together received 574 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (17 papers), Cancer-related Molecular Pathways (6 papers) and Protein Degradation and Inhibitors (6 papers). The work is most often cited by research in Oncology (223 citations), Molecular Biology (516 citations) and Cell Biology (68 citations). Mark A. Nakasone has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include David Fushman, Michael H. Glickman, Brian O. Smith, Danny T. Huang, Nurit Livnat‐Levanon, Gary Sibbet, Mads Gabrielsen, Carlos A. Castañeda, Robert E. Cohen and Susan Krueger. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.